ESR1 and breast cancer: Earlier, several subtype-specific differences in drug sensitivity were observed (Heiser et al. 2012) and since breast cancer subtypes are biologically very different (Parker et al. 2009), we also explored whether drug response in our study was ER- or subtype-related.